Software Engineer in Test Intern

IDDI joins Veeva CRO Partner Program to expand eClinical technology offerings for clinical trials. July 17, 2026. BRUSSELS; RALEIGH, N.C.; July. 16, 2026 - IDDI today announced it has joined the Veeva CRO Partner Program, further expanding its eClinical technology ecosystem to support sponsors running clinical trials of all sizes and complexities. As a leading provider of biometrics services, including biostatistics, data management, RTSM, and strategic consulting, IDDI is committed to helping sponsors select the technologies that best fit their protocol requirements and operational needs. Through this partnership, IDDI will expand the range of eClinical solutions available to its customers by adding Veeva Clinical Data applications, including Veeva EDC, Veeva DQS, Veeva eCOA, and Veeva RTSM. By combining scientific expertise with advanced technology solutions, IDDI helps sponsors build efficient, scalable clinical trial strategies that support high-quality data collection, streamlined study execution, and successful clinical outcomes. "Sponsors need the flexibility to build clinical technology ecosystems that support their unique study requirements," said Tara Kervin, Chief Operating Officer at IDDI. "By joining the Veeva CRO Partner Program, we are expanding our eClinical technology portfolio with Veeva's EDC, DQS, eCOA, and RTSM solutions. Together, we can better align technology with protocol design, giving sponsors greater choice while helping them execute studies more efficiently and confidently." The partnership reflects a shared commitment to providing life sciences organizations with modern, connected solutions that support efficient trial execution and enable teams to manage increasingly complex studies with confidence. About IDDI IDDI is a trusted clinical data science partner. With 35+ years of research-driven experience, IDDI Inc. combine therapeutic expertise, biostatistical leadership, and regulatory insight to mitigate risk from design to registration and beyond. IDDI Inc. deliver uncompromising excellence in biostatistics, strategic consulting, clinical data management, IDMCs, and supporting eClinical technologies, because when every data point represents a patient, perfection is the only option.

Stifel has reiterated its Buy rating and $230 price target on Veeva Systems following the company's acquisition of Copli, an agentic medical, legal and regulatory solutions firm. Veeva rebranded the acquisition as Veeva Falcon MLR, claiming the solution can eliminate 70% or more of manual MLR labour within five years. The system conducts compliance checks on promotional and medical materials against approved labels and local regulations. Separately, Veeva launched Veeva EHS on 25 June, a new environmental, health and safety application within its Veeva Quality Cloud. Veeva Systems delivers industry cloud solutions for life sciences, offering software, AI, data and consulting services.

Veeva Systems has announced Veeva EHS, a new environmental, health and safety application within Veeva Quality Cloud. The solution enables manufacturing and testing sites to identify, manage and mitigate operational and environmental risks whilst ensuring global compliance readiness. Veeva EHS integrates directly with Veeva QMS and Veeva Training, allowing safety events to automatically trigger quality deviations and assign targeted retraining. This eliminates duplicate data entry and streamlines workflows across the entire EHS process. The application provides real-time insights into leading risk indicators and uses intelligent automation to improve site efficiency. Planned for early adopter availability in August 2026, Veeva EHS represents a significant advancement in how organisations manage environmental, health and safety responsibilities through a unified platform.